Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study

202397 citationsJournal Articlegold Open Access

Authors

Bayer/Bristol Myers Squibb.

Good health and well-being

Published in: EClinicalMedicine

Volume 58, pp. 101917-101917

Field-Weighted Citation Impact: 22.00